Targeting the CaVα-CaVβ interaction yields an antagonist of the N-type CaV2.2 channel with broad antinociceptive efficacy. - Khanna, Rajesh; Yu, Jie; Yang, Xiaofang; Moutal, Aubin; Chefdeville, Aude; Gokhale, Vijay; Shuja, Zunaira; Chew, Lindsey A.; Bellampalli, Shreya S.; Luo, Shizhen; François-Moutal, Liberty; Serafini, Maria J.; et al. (PAIN, 2019)